XML 49 R40.htm IDEA: XBRL DOCUMENT
v3.23.2

Note 7 - Share-based Compensation - Stock-settled Stock Appreciation Rights Transactions (Details) - USD ($) $ / shares in Units, $ in Thousands | 6 Months Ended | 12 Months Ended
--- | --- | ---
Jun. 30, 2023 | Dec. 31, 2022
Lapsed or cancelled (in shares) |  | (133,173) |
Lapsed or cancelled, weighted average exercise price (in dollars per share) |  | $ 18.52 |
Stock Appreciation Rights (SARs) [Member] |  |  |
Outstanding SARS (in shares) |  | 320,385 |
Outstanding (in dollars per share) |  | $ 15.23 |
Outstanding SARS, weighted average remaining life (Year) |  | 2 years 4 months 28 days | 2 years 2 months 23 days
Outstanding SARS, aggregate intrinsic value |  | $ 43 | $ 69
Granted SARs (in shares) | [1] | 51,209 |
Granted SARS, weighted average exercise price (in dollars per share) |  | $ 12.04 |
Exercised SARs (in shares) |  | 0 |
Exercised SARS, weighted average exercise price (in dollars per share) |  | $ 0 |
Lapsed or cancelled (in shares) |  | (37,860) |
Lapsed or cancelled, weighted average exercise price (in dollars per share) |  | $ 23.62 |
Outstanding SARS (in shares) |  | 333,734 | 320,385
Outstanding SARS, weighted average exercise price (in dollars per share) |  | $ 13.79 | $ 15.23
Exercisable (in shares) |  | 225,471 |
Exercisable, weighted average exercise price (in dollars per share) |  | $ 13.47 |
Exercisable SARS, weighted average remaining life (Year) |  | 1 year 6 months 14 days |
Exercisable, aggregate intrinsic value |  | $ 43 |
[1] | The weighted average grant date fair value of SARs granted was $4.58 per share.

X
- Definition The weighted average exercise price for non-option equity instruments. + References No definition available. + Details
Name: | sgc_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsNonOptionOutstandingWeightedAverageGrantDateFairValue
Namespace Prefix: | sgc_
Data Type: | dtr-types:perShareItemType
Balance Type: | na
Period Type: | instant

X
- Definition The weighted average grant-date fair value of SARS exercised during the reporting period as calculated by applying the disclosed option pricing methodology. + References No definition available. + Details
Name: | sgc_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExercisedInPeriodWeightedAverageGrantDateFairValue
Namespace Prefix: | sgc_
Data Type: | dtr-types:perShareItemType
Balance Type: | na
Period Type: | duration

X
- Definition The weighted average exercise price of non-option equity instruments granted during the period. + References No definition available. + Details
Name: | sgc_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantedInPeriodWeightedAverageGrantDateFairValue
Namespace Prefix: | sgc_
Data Type: | dtr-types:perShareItemType
Balance Type: | na
Period Type: | duration

X
- Definition Amount of difference between fair value of the underlying shares reserved for issuance and exercise price of vested portions of non-option equity awards outstanding and currently exercisable. + References No definition available. + Details
Name: | sgc_SharebasedCompensationArrangementBySharebasedPaymentAwardNonoptionEquityInstrumentsExercisableIntrinsicValue
Namespace Prefix: | sgc_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | instant

X
- Definition Number of non-option equity instruments exercisable. + References No definition available. + Details
Name: | sgc_SharebasedCompensationArrangementBySharebasedPaymentAwardNonoptionEquityInstrumentsExercisableNumber
Namespace Prefix: | sgc_
Data Type: | xbrli:sharesItemType
Balance Type: | na
Period Type: | instant

X
- Definition Weighted average price at which the shares can be exercisable. + References No definition available. + Details
Name: | sgc_SharebasedCompensationArrangementBySharebasedPaymentAwardNonoptionEquityInstrumentsExercisableWeightedAverageExercisePrice
Namespace Prefix: | sgc_
Data Type: | dtr-types:perShareItemType
Balance Type: | na
Period Type: | instant

X
- Definition Weighted average remaining contractual term for vested portions of non-options equity instruments outstanding and currently exercisable or convertible, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. + References No definition available. + Details
Name: | sgc_SharebasedCompensationArrangementBySharebasedPaymentAwardNonoptionEquityInstrumentsExercisableWeightedAverageRemainingContractualTerm
Namespace Prefix: | sgc_
Data Type: | xbrli:durationItemType
Balance Type: | na
Period Type: | duration

X
- Definition Amount by which the current fair value of the underlying stock exceeds the exercise price of non-option equity awards outstanding. + References No definition available. + Details
Name: | sgc_SharebasedCompensationArrangementBySharebasedPaymentAwardNonoptionEquityInstrumentsOutstandingIntrinsicValue
Namespace Prefix: | sgc_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | instant

X
- Definition Weighted average remaining contractual term for non-option equity awards outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. + References No definition available. + Details
Name: | sgc_SharebasedCompensationArrangementBySharebasedPaymentAwardNonoptionEquityInstrumentsOutstandingWeightedAverageRemainingContractualTerm
Namespace Prefix: | sgc_
Data Type: | xbrli:durationItemType
Balance Type: | na
Period Type: | duration

X
- Definition Number of non-option equity instruments exercised by participants. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (c)(1)(iv)(2) -SubTopic 10 -Topic 718 -Publisher FASB -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2 + Details
Name: | us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised
Namespace Prefix: | us-gaap_
Data Type: | xbrli:sharesItemType
Balance Type: | na
Period Type: | duration

X
- Definition Net number of non-option equity instruments granted to participants. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (c)(1)(iv)(1) -SubTopic 10 -Topic 718 -Publisher FASB -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2 + Details
Name: | us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted
Namespace Prefix: | us-gaap_
Data Type: | xbrli:sharesItemType
Balance Type: | na
Period Type: | duration

X
- Definition Number of equity instruments other than options outstanding, including both vested and non-vested instruments. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (c)(1)(i) -SubTopic 10 -Topic 718 -Publisher FASB -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2 Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (c)(1)(ii) -SubTopic 10 -Topic 718 -Publisher FASB -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2 + Details
Name: | us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber
Namespace Prefix: | us-gaap_
Data Type: | xbrli:sharesItemType
Balance Type: | na
Period Type: | instant

X
- Definition Number of options or other stock instruments for which the right to exercise has lapsed under the terms of the plan agreements. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 718 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (c)(1)(iv)(04) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2 + Details
Name: | us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod
Namespace Prefix: | us-gaap_
Data Type: | xbrli:sharesItemType
Balance Type: | na
Period Type: | duration

X
- Definition Weighted average price at which grantees could have acquired the underlying shares with respect to stock options of the plan that expired. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 718 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (c)(1)(iv)(04) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2 + Details
Name: | us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:perShareItemType
Balance Type: | na
Period Type: | duration

X
- Details
Name: | us-gaap_AwardTypeAxis=us-gaap_StockAppreciationRightsSARSMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |